1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Multiple Sclerosis Therapeutics Market – By Drug Class

1.3.2        Asia Pacific Multiple Sclerosis Therapeutics Market – By Route of Administration

1.3.3        Asia Pacific Multiple Sclerosis Therapeutics Market – By Distribution Channel

1.3.4        Asia Pacific Multiple Sclerosis Therapeutics Market – By Country

2.           Multiple Sclerosis Therapeutics Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Multiple Sclerosis Therapeutics– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

4.3         Expert Opinions

5.           Multiple Sclerosis Therapeutics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Multiple Sclerosis (MS)

5.1.2        Rising Funding for Multiple Sclerosis Research

5.2         Market Restraints

5.2.1        High Cost of Multiple Sclerosis Treatment

5.3         Market Opportunities

5.3.1        Increasing Awareness About Multiple Sclerosis

5.4         Future Trends

5.4.1        Development and Launch of Innovative Products

5.5         Impact analysis

6.           Multiple Sclerosis Therapeutics Market – Asia Pacific Analysis

6.1         Asia Pacific Multiple Sclerosis Therapeutics Market Revenue Forecast and Analysis

7.           Multiple Sclerosis Therapeutics Market Analysis – By Drug Class

7.1         Overview

7.2         Multiple Sclerosis Therapeutics Market Revenue Share, by Drug Class (2019 and 2027)

7.3         Immunosuppressant

7.3.1        Overview

7.3.2        Immunosuppressant: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Immunomodulators

7.4.1        Overview

7.4.2        Immunomodulators: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.           Multiple Sclerosis Therapeutics Market Analysis – By Route of Administration

8.1         Overview

8.2         Multiple Sclerosis Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

8.3         Injectable

8.3.1        Overview

8.3.2        Injectable: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Oral

8.4.1        Overview

8.4.2        Oral: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.           Multiple Sclerosis Therapeutics Market Analysis – By Distribution Channel

9.1         Overview

9.2         Multiple Sclerosis Therapeutics Market Share, by Distribution Channel, 2019 and 2027

9.3         Hospital Pharmacies

9.3.1        Overview

9.3.2        Hospital Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Retail Pharmacies

9.4.1        Overview

9.4.2        Retail Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.5         E-Commerce

9.5.1        Overview

9.5.2        E-Commerce: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.        Multiple Sclerosis Therapeutics Market Analysis and Forecast To 2027 – Asia Pacific Analysis

10.1      Asia Pacific Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027

10.1.1     Overview

10.1.2     Asia Pacific Multiple Sclerosis Therapeutics Market share, By Country (2019 & 2027) (%)

10.1.3     China Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.1       China Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.2       China Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.3.3       China Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

10.1.3.4       China Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.4     Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.1       Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.2       Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.4.3       Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

10.1.4.4       Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.5     India Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.1       India Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.2       India Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.5.3       India Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

10.1.5.4       India Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.6     South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1       South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2       South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.6.3       South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.6.4       South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.7     Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1       Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2       Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.7.3       Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

10.1.7.4       Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.8     Rest of Asia Pacific: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Asia Pacific Multiple Sclerosis Therapeutics Market

11.1      Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Novartis AG

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bristol-Myers Squibb Company

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Takeda Pharmaceutical Company Limited

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      F. HOFFMANN-LA ROCHE LTD.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Biogen

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             China Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 2.             China Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

Table 3.             China Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel  (US$ Mn)

Table 4.             Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 5.             Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

Table 6.             Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 7.             India Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 8.             India Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

Table 9.             India Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 10.          South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 11.          South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 12.          South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 13.          Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 14.          Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

Table 15.          Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 19.          Organic Developments Done By Companies

Table 20.          Inorganic Developments Done By Companies

Table 21.          Glossary of Terms, Multiple sclerosis therapeutics Market

LIST OF FIGURES

Figure 1.           Multiple Sclerosis Therapeutics Market Segmentation

Figure 2.           Multiple Sclerosis Therapeutics Market Segmentation, By Country

Figure 3.           Multiple Sclerosis Therapeutics Market Overview

Figure 4.           Immunomodulators Segment by Drug Class Held the Larger Share of Asia Pacific Multiple Sclerosis Therapeutics Market

Figure 5.           Asia Pacific Multiple Sclerosis Therapeutics Market – Leading Country Markets (US$ Million)

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Multiple Sclerosis Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8.           Asia Pacific Multiple Sclerosis Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9.           Multiple Sclerosis Therapeutics Market Revenue Share, by Drug Class (2019 and 2027)

Figure 10.        Immunosuppressant: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Immunomodulators: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Multiple Sclerosis Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 13.        Injectable: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Oral: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Multiple Sclerosis Therapeutics Market Share, by Distribution Channel, 2019 and 2027

Figure 16.        Hospital Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Retail Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        E-Commerce: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Asia Pacific Multiple Sclerosis Therapeutics Market Overview, by Country (2019)

Figure 20.        Asia Pacific Multiple Sclerosis Therapeutics Market share, By Country (2019 & 2027) (%)

Figure 21.        China Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Japan Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        India Multiple Sclerosis Therapeutic Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 24.        South Korea Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Australia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets